iX Biopharma issues 4.42 million new shares after warrant exercises

SGX Filings

Jun 30

iX Biopharma Ltd. announced that on Jun, 30 2026 it issued 4.42 million new ordinary shares following the exercise of warrants at 0.06 Singapore dollars per share. This raised the company’s total issued share capital from 1.06 billion to 1.07 billion shares.

The exercised warrants bring the cumulative total to 32.04 million, representing 55.70 % of all warrants initially issued, leaving 25.47 million warrants outstanding at an exercise price of 0.06 Singapore dollars each.

The new shares will begin trading on the Singapore Exchange on or around Jul, 02 2026 and will rank pari passu with existing shares. The warrants will cease trading after Jul, 10 2026, be suspended from Jul, 13 2026, and expire at 5:00 p.m. on Jul, 17 2026, after which any unexercised warrants will lapse. De-listing of the warrants is scheduled for Jul, 20 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1117734988"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1117734988\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1117734988?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 18:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117734988","market":"sg","top_or_hot":-1,"title":"iX Biopharma issues 4.42 million new shares after warrant exercises","media":"SGX Filings","content":"<p>iX Biopharma Ltd. announced that on Jun, 30 2026 it issued 4.42 million new ordinary shares following the exercise of warrants at 0.06 Singapore dollars per share. This raised the company’s total issued share capital from 1.06 billion to 1.07 billion shares.</p>\n<p>The exercised warrants bring the cumulative total to 32.04 million, representing 55.70 % of all warrants initially issued, leaving 25.47 million warrants outstanding at an exercise price of 0.06 Singapore dollars each.</p>\n<p>The new shares will begin trading on the Singapore Exchange on or around Jul, 02 2026 and will rank pari passu with existing shares. The warrants will cease trading after Jul, 10 2026, be suspended from Jul, 13 2026, and expire at 5:00 p.m. on Jul, 17 2026, after which any unexercised warrants will lapse. De-listing of the warrants is scheduled for Jul, 20 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iX Biopharma issues 4.42 million new shares after warrant exercises</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niX Biopharma issues 4.42 million new shares after warrant exercises\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2026-06-30 18:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>iX Biopharma Ltd. announced that on Jun, 30 2026 it issued 4.42 million new ordinary shares following the exercise of warrants at 0.06 Singapore dollars per share. This raised the company’s total issued share capital from 1.06 billion to 1.07 billion shares.</p>\n<p>The exercised warrants bring the cumulative total to 32.04 million, representing 55.70 % of all warrants initially issued, leaving 25.47 million warrants outstanding at an exercise price of 0.06 Singapore dollars each.</p>\n<p>The new shares will begin trading on the Singapore Exchange on or around Jul, 02 2026 and will rank pari passu with existing shares. The warrants will cease trading after Jul, 10 2026, be suspended from Jul, 13 2026, and expire at 5:00 p.m. on Jul, 17 2026, after which any unexercised warrants will lapse. De-listing of the warrants is scheduled for Jul, 20 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"42C.SI","symbol_name":"IX生物制药","start_time":0,"source_url":"","article_id":"1117734988","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117734988","pubTimestamp":1782814220,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"iX Biopharma Ltd. announced that on Jun, 30 2026 it issued 4.42 million new ordinary shares following the exercise of warrants at 0.06 Singapore dollars per share. This raised the company’s total...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"42C.SI":"IX生物制药"},"translate_title":"iX Biopharma认股权证行使后发行442万股新股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"42C.SI":1},"content_text":"iX Biopharma Ltd. announced that on Jun, 30 2026 it issued 4.42 million new ordinary shares following the exercise of warrants at 0.06 Singapore dollars per share. This raised the company’s total issued share capital from 1.06 billion to 1.07 billion shares.\nThe exercised warrants bring the cumulative total to 32.04 million, representing 55.70 % of all warrants initially issued, leaving 25.47 million warrants outstanding at an exercise price of 0.06 Singapore dollars each.\nThe new shares will begin trading on the Singapore Exchange on or around Jul, 02 2026 and will rank pari passu with existing shares. The warrants will cease trading after Jul, 10 2026, be suspended from Jul, 13 2026, and expire at 5:00 p.m. on Jul, 17 2026, after which any unexercised warrants will lapse. De-listing of the warrants is scheduled for Jul, 20 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}